HeartBeam (BEAT) Capital Expenditures (2023 - 2026)

HeartBeam (BEAT) posted quarterly Capital Expenditures of $114000.0 for Q1 2026, down 77.95% quarter-over-quarter from $517000.0 in Q4 2025.

HeartBeam (BEAT) Capital Expenditures (2023 - 2026) Analysis & Trends

HeartBeam (BEAT) has reported Capital Expenditures for 4 consecutive years, with $114000.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Capital Expenditures changed N/A year-over-year to $114000.0; the TTM figure through Mar 2026 stood at $714000.0 (changed N/A YoY), while the FY2025 annual figure was $600000.0, changed N/A from the prior year.
Capital Expenditures fell to $114000.0 in Q1 2026 per BEAT's latest filing, from $517000.0 in the prior quarter.
Across five years, Capital Expenditures topped out at $517000.0 in Q4 2025 and bottomed at -$98000.0 in Q3 2024.
Historically, Capital Expenditures has averaged $121250.0 across 4 years, with a median of $105000.0 in 2023.
Annual changes were most pronounced in 2024 — Capital Expenditures slumped 168.06% — and 2025, when it jumped 157.14%.
HeartBeam's Capital Expenditures stood at $112000.0 in 2023, then tumbled by 187.5% to -$98000.0 in 2024, then soared by 627.55% to $517000.0 in 2025, then slumped by 77.95% to $114000.0 in 2026.
Business Quant data shows BEAT's Capital Expenditures at $114000.0 in Q1 2026, $517000.0 in Q4 2025, and $56000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	1.75 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	29.03 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	15.93 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	1.59 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	1.73 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	56.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	16.11 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	2.32 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	HeartBeam	28.17 Mn	19.45 Mn	-	249,000.00

Download Data